FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes

(MedPage Today) -- The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday.
Like its reference counterpart, insulin aspart (Novolog...